Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials
J Am Coll Cardiol
; 70(23): 2863-2874, 2017.
Article
in English
| Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP
| ID: biblio-1063635
Responsible library:
BR79.1
Localization: BR79.1
ABSTRACT
BACKGROUND:
Procedural technique may affect clinical outcomes after bioresorbable vascular scaffold (BVS) implantation. Prior studies suggesting such a relationship have not adjusted for baseline patient and lesion characteristics that may have influenced operator choice of technique and outcomes.OBJECTIVES:
This study sought to determine whether target lesion failure (TLF) (cardiac death, target-vessel myocardial infarction, or ischemia-driven target lesion revascularization) and scaffold thrombosis (ScT) rates within 3 years of BVS implantation are affected by operator technique (vessel size selection and pre- and post-dilation parameters).METHODS:
TLF and ScT rates were determined in 2,973 patients with 3,149 BVS-treated coronary artery lesions from 5 prospective studies (ABSORB II, ABSORB China, ABSORB Japan, ABSORB III, and ABSORB Extend). Outcomes through 3 years (and between 0 to 1 and 1 to 3 years) were assessed according to pre-specified definitions of optimal technique (pre-dilation, vessel sizing, and post-dilation). Multivariable analysis was used to adjust for differences in up to 18 patient and lesion characteristics...
Search on Google
Collection:
National databases
/
Brazil
Database:
Sec. Est. Saúde SP
/
SESSP-IDPCPROD
Main subject:
Thrombosis
/
Vascular Diseases
/
Vascular Surgical Procedures
/
Myocardial Revascularization
Type of study:
Observational study
Language:
English
Journal:
J Am Coll Cardiol
Year:
2017
Document type:
Article
Institution/Affiliation country:
Cleveland Clinic/US
/
Fortis Escorts Heart Institute/IN
/
Fu Wai Hospital, National Center for Cardiovascular Diseases/CN
/
Institut Cardiovasculaire Paris Sud/FR
/
Instituto Dante Pazzanese de Cardiologia/BR
/
Kyoto University Hospital/JP
/
National Heart and Lung Institute, Imperial College London/GB
/
New York Presbyterian Hospital/US
/
New York Presbyterian Hospital, Columbia University Medical Center/US
/
The Cardiovascular Research Foundation/US